Edwards Lifesciences Corp (NYSE:EW)
| 96.82 Delayed Data As of 3:59pm ET |  +2.28 / +2.41%Today’s Change | 91.52 Today|||52-Week Range 131.73 | -25.26% Year-to-Date |
Latest EW News | Press Releases
No recent news for Edwards Lifesciences Corp.
Today’s Trading
| Previous close | 94.54 |
| Today’s open | 93.88 |
| Day’s range | 93.66 - 97.19 |
| Volume | 3,832,909 |
| Average volume (3 months) | 2,838,969 |
| Market cap | $58.6B |
Data as of 3:59pm ET, 05/25/2022
Growth & Valuation
| Earnings growth (last year) | +82.34% |
| Earnings growth (this year) | +15.48% |
| Earnings growth (next 5 years) | +13.22% |
| Revenue growth (last year) | +19.29% |
| P/E ratio | 39.9 |
| Price/Sales | 15.63 |
| Price/Book | 10.09 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ISRGIntuitive Surgical | +4.24 | +1.94% |
| SYKStryker Corp | +1.74 | +0.75% |
| STESTERIS plc | -0.24 | -0.11% |
| SNNSmith & Nephew PLC | +0.09 | +0.28% |
Data as of 4:00pm ET, 05/25/2022
Financials
| Next reporting date | July 28, 2022 |
| EPS forecast (this quarter) | $0.64 |
| Annual revenue (last year) | $5.2B |
| Annual profit (last year) | $1.5B |
| Net profit margin | 28.73% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
